Close menu




August 22nd, 2022 | 13:57 CEST

Joe Biden boosts hydrogen stocks: Nel ASA, Plug Power, dynaCERT in rally mode

  • Hydrogen
  • climatechange
  • Technology
Photo credits: pixabay.com

Hydrogen technology is now gaining momentum to energize our climate change efforts. Joe Biden has had to negotiate long and hard, but now his USD 430 billion Climate & Health Bill is in the history books. With the President's signature, the legislative package is now officially in effect as of last week. GreenTech is on everyone's lips because, not least since the Ukraine crisis, the world knows about the dangerous dependence on fossil fuels. It is just a shame that every Republican voted against these resolutions in the US Senate vote. Some shares reacted with leaps of joy.

time to read: 4 minutes | Author: André Will-Laudien
ISIN: NEL ASA NK-_20 | NO0010081235 , PLUG POWER INC. DL-_01 | US72919P2020 , DYNACERT INC. | CA26780A1084

Table of contents:


    Plug Power - The stock market darling deflates a bit

    Biden's original plans for climate protection and social reforms were among the core projects of his term. While the current package provides the most comprehensive investment in the US to combat climate change, according to government figures, the present package is a compromise because of disputes within the Democrats. That is because it contains only a fraction of what Biden once wanted to pass. The fact that the law was passed at all is nevertheless a victory for the President - until recently, it was hardly expected. The climate protection measures included are intended to reduce climate-damaging CO2 emissions in the US by around 40% by 2030 compared to 2005.

    H2 stock market darling Plug Power had already staged a pronounced rally before the law was passed. Since the lows in May, the value was able to put a remarkable 120% recovery together. It was primarily boosted by statements favouring decarbonized global mobility and some good deals. Plug Power is looking to land a fair amount of public budgets and plans to quadruple sales by 2026 on current sales of just under USD 1 billion in 2022. The Latham, New York-based group, wants to reach profitability as early as 2025. Even though analysts calculate a median price target of USD 37.46, a price-to-sales ratio of 16.6 is already exceptionally high and characterized by a lot of imagination. The value has only lost 12% in the last week, a healthy consolidation after the politically induced buying panic. Wait and see where the current consolidation leads.

    dynaCERT - Strong rebound points to upcoming certification

    We have already discussed the Canadian technology company dynaCERT many times. After a strong share price consolidation due to Corona-related showstoppers, the stock is currently experiencing a revival. From the bombed-out level at about CAD 0.10, the value recovered with huge turnovers by the end of last week by a full 80% to CAD 0.18.

    There are several reasons for this: The company was one of the technology pioneers to look at the benefits of hydrogen technology very early on and now has good name recognition and market access in North America. It fits perfectly with Joe Biden's announced Climate Bill. In addition, dynaCERT has been engaged for several months in the certification process of VERRA, the globally recognized institute for CO2 certificate approval, which provides an important proof of concept, especially for disruptive technologies. VERRA's global standards and frameworks serve as a linchpin for channeling funding into activities that address some of our time's most pressing environmental issues. The allocation is likely to be immediately anticipated by the Exchange. If it comes, the way will be clear for a nationwide rollout of dynaCERT technology. Contracts like Plug Power together with Walmart would then be possible for larger fleet associations in North America. Anyone familiar with the truck density on North America's freeways will be able to appreciate the dimensions for potential energy savings.

    At the upcoming IAA for commercial vehicles in Hanover in September, the stage is set for a comprehensive presentation of the technical solutions, into which more than CAD 50 million in development costs have already flowed since 2018. However, the DYA share will likely celebrate the expected news and trade show appearance accordingly before then. The stock is speculative but highly interesting.

    Nel ASA - First consolidation after the figures

    The Norwegian hydrogen company Nel ASA presented its half-year figures on 11.08. The shares then went into reverse gear for the time being because the analysts' expectations could not be reached by far. Thus, sales in the second quarter increased by 12% from NOK 163.7 to 183 million, but the experts had expected NOK 244 million. The bottom line is still a loss of NOK 0.18 per share, which also deviates by around 25% from consensus estimates.

    EBITDA was NOK -197 million after NOK -120 million due to high investments, but order intake reached NOK 236 million in the second quarter. That is still 61% more than in the same quarter last year, and at NOK 1.439 billion, the order book is fuller than ever. A further capital increase in the first half of the year enabled Nel to expand its cash position to over NOK 3.6 billion by the reporting date, and that helped for the acceptance of expected public orders. Nel is dependent on these, as the private sector's willingness to invest in H2 technologies is still very low.

    With a current P/S ratio of 24, the stock is anything but cheap. From a chart perspective, the volatile stock should not fall below the EUR 1.47 mark again; otherwise, there is a threat of trouble. Overall, the Nel share is a speculative hopeful on erratic developments within the H2 sector, but investors should set a tight stop. See the update on this at researchanalyst.com.


    Hydrogen technology has relevance in the fight against atmospheric warming. Therefore, the sector always benefits from positive news about new government budgets. The current valuation of the sector protagonists is correspondingly high. Those who invest in a diversified manner reduce their portfolio risk.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as shareholders, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price development. In this context, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). The Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.

    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    Apaton Finance GmbH reserves the right to enter into paid contractual relationships with the company or with third parties in the future with regard to reports about the company that are reported on the Apaton Finance GmbH website as well as in social media, on partner sites or in e-mail messages.
    The above information on conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications about companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by Armin Schulz on October 4th, 2022 | 10:58 CEST

    JinkoSolar, TubeSolar, Encavis - Shares for the energy turnaround

    • agritech
    • renewableenergies
    • Technology

    The phase-out of fossil energy generation is a done deal in Germany, but there is still a long way to go. Germany's share of renewable energies in electricity generation was 42.4% in 2021. However, this covered only 19.7% of Germany's energy consumption. Since the flare-up of the Ukraine crisis, the expansion of renewable energies is to be accelerated. A balanced mix is essential. Spring and summer are the main times for solar power, while in fall and winter, when the days are shorter, wind power is the primary source of electricity. If we want to achieve the 2030 targets, a massive expansion is essential. Today we take a look at three renewable energy companies.

    Read

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...

    Read

    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.

    Read